AU8016094A - Method of contraception - Google Patents
Method of contraceptionInfo
- Publication number
- AU8016094A AU8016094A AU80160/94A AU8016094A AU8016094A AU 8016094 A AU8016094 A AU 8016094A AU 80160/94 A AU80160/94 A AU 80160/94A AU 8016094 A AU8016094 A AU 8016094A AU 8016094 A AU8016094 A AU 8016094A
- Authority
- AU
- Australia
- Prior art keywords
- contraception
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US136077 | 1980-03-28 | ||
US13607793A | 1993-10-12 | 1993-10-12 | |
PCT/US1994/011588 WO1995010298A1 (en) | 1993-10-12 | 1994-10-12 | Method of contraception |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8016094A true AU8016094A (en) | 1995-05-04 |
Family
ID=22471179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU80160/94A Abandoned AU8016094A (en) | 1993-10-12 | 1994-10-12 | Method of contraception |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU8016094A (en) |
WO (1) | WO1995010298A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
AU748575B2 (en) * | 1996-02-09 | 2002-06-06 | Swedish Orphan Biovitrum Ab (Publ) | Composition comprising interleukin-1 inhibitor and controlled release polymer |
SK288144B6 (en) * | 1996-02-09 | 2013-12-02 | Amgen, Inc. | Pharmaceutical composition and its use for treating inflammatory diseases |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
AU778759B2 (en) | 1998-12-23 | 2004-12-16 | Genentech Inc. | IL-1 related polypeptides |
HUP0400698A3 (en) * | 2001-02-06 | 2006-01-30 | Merck Patent Gmbh | Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
GB0708376D0 (en) * | 2007-05-01 | 2007-06-06 | Alligator Bioscience Ab | Novel polypeptides and uses thereof |
ES2952394T3 (en) | 2010-07-29 | 2023-10-31 | Buzzard Pharmaceuticals AB | Chimeric IL-1 type I receptor antagonists |
SG10201707477SA (en) | 2013-03-13 | 2017-10-30 | Eleven Biotherapeutics Inc | Chimeric cytokine formulations for ocular delivery |
AU2016235298B2 (en) | 2015-03-23 | 2021-03-11 | Evestra, Inc. | Novel cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4961436A (en) * | 1987-07-17 | 1990-10-09 | Brigham And Women's Hospital | Contraceptive cervical cap |
US5116619A (en) * | 1988-08-30 | 1992-05-26 | Lee Roy Morgan | Vaginal progesterone tablet |
-
1994
- 1994-10-12 AU AU80160/94A patent/AU8016094A/en not_active Abandoned
- 1994-10-12 WO PCT/US1994/011588 patent/WO1995010298A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995010298A1 (en) | 1995-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4013193A (en) | Method of maintaining relationships between elements | |
AU7557594A (en) | Method of fertilizer application | |
AU1322195A (en) | Method of assay | |
AU7968694A (en) | Bags and method of making bags | |
AU7700896A (en) | Method of orienting cans | |
AU4868493A (en) | Method of combining polymers | |
AU8016094A (en) | Method of contraception | |
AU6752294A (en) | Preparation process of acrylamide | |
PL313740A1 (en) | Method of | |
AU3385693A (en) | Determination method | |
AU6723294A (en) | Use of simmondsine | |
AU6368394A (en) | Polymer-polypeptide composition and method | |
AU3342093A (en) | Lens and method of making same | |
EP0821576A4 (en) | Method of contraception | |
AU1197495A (en) | Method for abandonment of subseawells | |
AU7590794A (en) | Method of sealing | |
AU1287095A (en) | Package and method of making said package | |
AU1674295A (en) | Preparation of doped polycarbynes | |
AU6905994A (en) | Method of mining | |
AU7131094A (en) | Method of laminate manufacture | |
AU3847693A (en) | One-pot process | |
AU8099694A (en) | Method of preventing disasters | |
AU7338294A (en) | Method for endomodification of proteins | |
RU2003311C1 (en) | Method of blepharorrhaphy | |
AU7239194A (en) | Method of suppressing sweetness |